Safety and efficacy of a five-fraction stereotactic body radiotherapy schedule for centrally located non–small-cell lung cancer: NRG Oncology/RTOG 0813 trial

  • Andrea Bezjak
  • , Rebecca Paulus
  • , Laurie E. Gaspar
  • , Robert D. Timmerman
  • , William L. Straube
  • , William F. Ryan
  • , Yolanda I. Garces
  • , Anthony T. Pu
  • , Anurag K. Singh
  • , Gregory M. Videtic
  • , Ronald C. McGarry
  • , Puneeth Iyengar
  • , Jason R. Pantarotto
  • , James J. Urbanic
  • , Alexander Y. Sun
  • , Megan E. Daly
  • , Inga S. Grills
  • , Paul Sperduto
  • , Daniel P. Normolle
  • , Jeffrey D. Bradley
  • Hak Choy

Research output: Contribution to journalArticlepeer-review

494 Scopus citations

Fingerprint

Dive into the research topics of 'Safety and efficacy of a five-fraction stereotactic body radiotherapy schedule for centrally located non–small-cell lung cancer: NRG Oncology/RTOG 0813 trial'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science